Dialysis patients with acne: Efficacy and safety of isotretinoin treatment: About an observation;Intérêt de l'isotrétinoïne dans le traitement de l'acné de l'hémodialysé(e): À propos d'une observation

Nephrologie

Volumn 24, Issue 2, 2003, Pages 101-105

  Montagnac, Richard ^a   Reguiai Z ^a   Bressieux, J M ^a   Schillinger, F ^a  

^a CENTRE HOSPITALIER DE TROYES   (France)

Author keywords

Acne; Chronic renal failure; Hemodialysis; Isotretinoin; Renal transplant

Indexed keywords

ISOTRETINOIN; PARATHYROID HORMONE;

ACNE; ADULT; ARTICLE; CASE REPORT; DIALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION;

ACNE VULGARIS; ADULT; FEMALE; GRAFT REJECTION; HUMANS; ISOTRETINOIN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; RENAL DIALYSIS;

EID: 0344838633     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fuchs E, Lynfield Y. Dialysis acne. J Am Acad Dermatol 1990; 23: 125.
2. Tam M, Cooper A. The use of isotretinoin in a renal transplant patient with acne. Br J Dermatol 1987; 116: 463.
3. Marcusson JA, Tyden G. Acne conglobata in transplant patients treated with isotretinoin. Br J Dermatol 1988; 118: 310-1.
4. Beightler EL, Tyring SK. The use of isotretinoin in a patient undergoing kidney hemodialysis. J Am Acad Dermatol 1990; 23: 758.
5. Grange F, Mitschler A, Genestier S, Guillaume JC. Acné prurigineuse grave chez l'insuffisant rénal chronique. Difficultés diagnostiques et efficacité de l'isotrétinoïne. Ann Dermatol Venereol 2001; 128: 1215-9
6. Lin JL, Shih IH, Yu CC. Hemodialysis-related nodulocystic acne treated with isotretinoin. Nephron 1999; 81: 146-50.
7. Humbert P. Acnés induites. Rev Prat 2002; 52: 838-40.
8. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1.
9. Charron A, Bessis D, Dereure O, Guilhou JJ, Guillot B. Effets secondaires cutanés locaux des interférons. Presse Med 2001; 30: 1555-60.
10. AFSSAPS. Traitement de l'acné par voie générale: argumentaire. Ann Dermatol Venereol 1999; 126: 224-31.
11. Beylot C. Acné. Thérapeutique dermatologique. Paris: Flammarion Ed., 2001; 6-18.
12. Popper H, Steigmann F, Dyniewicz HA. Plasma vitamin A levels in renal diseases. Am J Clin Pathol 1945; 15: 272-5.
13. Yatzidis H, Digenis P, Fountas P. Hypervitaminosis A accompanying advanced chronic renal failure. BMJ 1975; 3: 352-3.
14. Werb R, Clark WF, Lindsay RM, Jones EOP, Linton AL. Serum vitamin A levels and associated abnormalities in patients on regular dialysis treatment. Clin Nephrol 1979; 12: 63-8.
15. Praga M, Rubio PD, Morales JM, Canizares F. Implications of hypervitaminosis A on the calcium-phosphate metabolism and on blood lipids in hemodialysis. Am J Nephrol 1987; 7: 281-6.
16. Valentic JP, Elias AN, Weinstein GD. Hypercalcemia associated with oral isotretinoin in the treatment of severe acne. JAMA 1983; 250: 1899-900.
17. Bergman SM, O'Mailaia J, Krane NK, Wallin JD. Vitamin-A-induced hypercalcemia. Responses to corticosteroids. Nephron 1988; 50: 362-4.
18. Farrington K, Miller P, Varghese Z, Baillod RA, Moorhead JF. Vitamin A toxicity and hypercalcaemia in chronic renal failure. BMJ (Clin Res Ed) 1981; 282: 1999-2002.
19. Miller P, Sweny P, Persaud JW. The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure. Proc Eur Dial transplant Assoc 1981; 18: 573-8.
20. Gleghorn EE, Eisenberg LD, Hack S, Parton P, Merritt RJ. Observations of vitamin A toxicity in three patients with renal failure receiving parenteral alimentation. Am J Clin Nutr 1986; 44: 107-12.
21. Fishbane S, Frei GL, Finger M, Dressler R, Silbiger S. Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis 1995; 25: 346-9.
22. Doireau V, Macher MA, Brun P, Bernard O, Loirat C. Vitamin A poisoning revealed by hypercalcemia in a child with kidney failure. Arch Pediatr 1996; 3: 888-90.
23. Raisz LG. Bone resorption in tissue culture. Factors influencing the response to parathyroid hormone. J Clin Invest 1965; 44: 103-16.
24. Clark I, Smith MR. Effects of hypervitaminosis A and D on skeletal metabolism. J Biol Chem 1964; 239: 1266-71.
25. Hood AF, Hardegen GL, Zarate AR, Nigra TP, Gelfand MC. Kyrle's disease in patients with chronic renal failure. Arch Dermatol 1982; 118: 85-8.
26. Saleh HA, Lloyd KM, Fatteh S. Kyrle's disease effectively treated by isotretinoin. J Fla Med Assoc 1993; 80: 395-7.
27. Chertow BS, Williams GA, Norris RM, Baker GR, Hargis GK. Vitamin A stimulation of parathyroid hormone: Interactions with calcium, hydrocortisone and vitamin E in bovine parathyroid tissues and effects of vitamin A in man. Eur J Clin Invest 1977; 7: 307-14.
28. Rylance PB, Brown IR, Howells DW, Nisbet JA, Stone AN, Eastwood JB. Relationship between vitamin A and bone disease in chronic renal failure. Nephron 1984; 36: 131-5.
29. Stein G, Abendroth K, Kokot F, Keil E, Schone S, Wessel G, Funfstuck R, Sperschneider H. Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy. Z Urol Nephrol 1985; 78: 159-65.
30. Mc Donald PN, Ritter C, Brown AJ, Slatopolsky E. Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathroid cell culture. J Clin Invest 1994; 93: 725-30.
31. Gonzalez EA, Martin KJ. Retinoids modulate the effect of PTH and calcitriol on EGF receptor expression in UMR 106-01 celles. Calcif Tissue Int 1996; 58: 429-34.
32. Hellman P, Liu W, Westin G, Torma H, Akerstrom G. Vitamin D and retinoids in parathyroid glands (review). Int J Mol Med 1999; 3: 355-61.